Ignite Creation Date:
2025-12-24 @ 12:41 PM
Ignite Modification Date:
2025-12-30 @ 3:14 AM
Study NCT ID:
NCT00903461
Status:
TERMINATED
Last Update Posted:
2017-02-15
First Post:
2009-05-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy of Radiation/Cetuximab Plus EGFR Antisense DNA for Head and Neck Squamous Cell Carcinoma
Sponsor:
University of Pittsburgh
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-04
Start Date Type:
None
Primary Completion Date:
2015-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-08
Completion Date Type:
ACTUAL
First Submit Date:
2009-05-14
First Submit QC Date:
None
Study First Post Date:
2009-05-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-02-14
Last Update Post Date:
2017-02-15
Last Update Post Date Type:
ACTUAL